Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

United States to approve potent oral drugs for hepatitis C

Nature (2013)Cite this article

Subjects

Improved treatments offer hope for eradication of viral liver infection.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Sara Reardon
    View author publications

    You can also search for this author inPubMed Google Scholar

Related links

Related links

Related links in Nature Research

All-oral HCV therapies near approval 2013-May-31

Targeted drugs to tackle hepatitis C 2013-May-01

New drug targets raise hopes for hepatitis C cure 2011-Apr-26

Related external links

The Liver Meeting 2013, 64th Annual Meeting of the AASLD

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reardon, S. United States to approve potent oral drugs for hepatitis C. Nature (2013). https://doi.org/10.1038/nature.2013.14059

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2013.14059

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research